GAMMA Investing LLC increased its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 8,897.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 155,201 shares of the company's stock after acquiring an additional 153,476 shares during the quarter. GAMMA Investing LLC owned about 0.06% of Ryan Specialty worth $11,465,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of RYAN. Vanguard Group Inc. boosted its stake in shares of Ryan Specialty by 5.7% in the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after purchasing an additional 529,631 shares in the last quarter. Bessemer Group Inc. raised its holdings in Ryan Specialty by 2.5% during the 4th quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock worth $210,651,000 after purchasing an additional 79,976 shares during the last quarter. Blair William & Co. IL raised its holdings in Ryan Specialty by 0.6% during the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock worth $177,464,000 after purchasing an additional 16,540 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Ryan Specialty by 115.2% in the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after acquiring an additional 981,505 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of Ryan Specialty by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock valued at $115,468,000 after acquiring an additional 46,960 shares in the last quarter. 84.82% of the stock is owned by institutional investors.
Insider Activity at Ryan Specialty
In other news, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the transaction, the director now owns 71,467 shares of the company's stock, valued at $5,059,863.60. The trade was a 6.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. 52.21% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of analysts have commented on the stock. Barclays decreased their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Keefe, Bruyette & Woods reduced their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Morgan Stanley increased their price target on shares of Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a research report on Monday, May 19th. UBS Group increased their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Finally, Royal Bank of Canada lowered their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, Ryan Specialty has a consensus rating of "Moderate Buy" and an average price target of $75.58.
View Our Latest Report on Ryan Specialty
Ryan Specialty Price Performance
RYAN traded down $0.04 on Wednesday, reaching $65.22. The company had a trading volume of 799,439 shares, compared to its average volume of 993,836. The company has a market cap of $17.11 billion, a price-to-earnings ratio of 94.52, a P/E/G ratio of 1.19 and a beta of 0.70. Ryan Specialty Holdings, Inc. has a 52-week low of $52.34 and a 52-week high of $77.16. The business has a 50 day simple moving average of $69.13 and a 200 day simple moving average of $68.59. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting the consensus estimate of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. During the same period last year, the firm posted $0.35 earnings per share. The business's revenue was up 25.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend was Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is currently 141.18%.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report